CAH Stock: Price, Earnings History and SEC Filings
Cardinal Health, Inc. (CAH) last traded at $250.48, down 0.24% on the latest session and up 12.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $2.91 against an analyst estimate of $2.42, a beat of 20.2%.
$250.48 -0.24%
1 month+12.58%
52-week high$259.84
52-week low$180.45
Volume1.94M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
CAH earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 11, 2026 | $2.91 | $2.42 | +20.25% |
| Mar 2026 | Apr 30, 2026 | $3.17 | $2.80 | +13.21% |
| Dec 2025 | Feb 5, 2026 | $2.63 | $2.39 | +10.04% |
| Sep 2025 | Oct 30, 2025 | $2.55 | $2.21 | +15.38% |
CAH beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for CAH
SEC filing data is not available right now. You can search for CAH on SEC EDGAR.
CAH news
- Is Buying McKesson Stock Near Its High A Bad Idea?Oct 30, 2026 · trefis.com
- Is It A Mistake To Buy Cardinal Health Stock At A High?Oct 29, 2026 · trefis.com
- West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top EstimatesOct 29, 2026 · finance.yahoo.com
- Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You TradeOct 27, 2026 · finance.yahoo.com
- Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings ResultsOct 27, 2026 · finance.yahoo.com
- Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026?Oct 27, 2026 · fool.com
- Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?Oct 24, 2026 · fool.com
- Amgen vs. Eli Lilly: Does the GLP-1 Mania Make LLY Stock a Better Buy in 2026?Oct 22, 2026 · fool.com
About Cardinal Health, Inc.
Cardinal Health, Inc. (CAH) is a US-listed public company on NYSE.